Edwards Lifesciences Corporation Financial Analyst Salaries in Los Angeles
The average Edwards Lifesciences Corporation Financial Analyst in Los Angeles earns an estimated $91,341 annually, which includes an estimated base salary of $78,940 with a $12,401 bonus. Edwards Lifesciences Corporation's Financial Analyst compensation is $3,965 more than the US average for a Financial Analyst. Financial Analyst salaries at Edwards Lifesciences Corporation in Los Angeles can range from $52,000 - $185,000.
In Los Angeles, The Finance Department at Edwards Lifesciences Corporation earns $10,611 more on average than the Sales Department.
Last updated a year ago.
- $78,940
- avg. base
- $12,401
- avg. bonus
Financial Analyst Salaries at Edwards Lifesciences Corporation
In Los Angeles, Financial Analysts earn $2,136 more than Senior Accountants, and $27,971 less than Accounting Managers.
Compensation at Edwards Lifesciences Corporation by Department
In Los Angeles, The Finance Department averages $10,611 more than the Sales Department, and $2,638 less than the HR Department
Financial Analyst Compensation by Gender (All Companies)
The average female Financial Analyst at companies similar size to Edwards Lifesciences Corporation reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.
Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Financial Analyst at companies similar size to Edwards Lifesciences Corporation reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.
How Financial Analysts at Edwards Lifesciences Corporation Rate Their Compensation
The majority of Financial Analysts at Edwards Lifesciences Corporation believe they're compensated fairly. 100% of Financial Analysts at Edwards Lifesciences Corporation say they receive annual bonuses, and the vast majority (74%) are satisfied with their benefits. See more compensation ratings at Edwards Lifesciences Corporation
